Yakira Capital Management’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History

Yakira Capital Management’s Portfolio KNTE Stock Details KNTE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-496,840	Closed	-$1.32M	–	334
2024 Q1	$1.32M	Buy	+496,840	New	+$1.23M	0.4%	70

Yakira Capital Management's KNTE Position: Q2 2024 in Review

Yakira Capital Management sold out of Kinnate Biopharma Inc. Common Stock (KNTE) in Q2 2024, closing a stake of 496,840 shares — an estimated $1.32M sold.

Yakira Capital Management first reported a position in KNTE in Q1 2024 and held it in 1 quarter. The position peaked at $1.32M in Q1 2024. 0 funds tracked by Wall St. Rank hold KNTE as of Q2 2024.

Yakira Capital Management reported no remaining Kinnate Biopharma Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Yakira Capital Management sold 496,840 Kinnate Biopharma Inc. Common Stock shares in Q2 2024, an estimated $1.32M.
Yakira Capital Management first reported a position in Kinnate Biopharma Inc. Common Stock in Q1 2024 and held it in 1 quarter.
Yakira Capital Management's Kinnate Biopharma Inc. Common Stock position peaked at $1.32M in Q1 2024.
0 funds tracked by Wall St. Rank held Kinnate Biopharma Inc. Common Stock as of Q2 2024.

Based on Yakira Capital Management's 13F filing for Q2 2024, filed 13 Aug 2024.